The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis c infection

Rheumatology International

Volumn 30, Issue 4, 2010, Pages 485-488

  Orge E ^a   Cefle A ^a   Yazici, A ^a   Gurel Polat N ^b   Hulagu, S ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Anti cyclic citrullinated peptide; Hepatitis C virus; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYMPTOM; BLOOD; IMMUNOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; RHEUMATOID FACTOR; YOUNG ADULT;

EID: 77949891654     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0997-1     Document Type: Article

References (18)

1. Cojocaru M, Cojocaru IM, Iacob SA (2004) Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection. Rom J Intern Med 42(4):709-714
2. Kadiroǧlu K, Göral V, Şit D, Çelik M, Yilmaz E (2005) The evaluation of the prevalance of extrahepatic findings in chronic hepatitis C virus infection. Turkiye Klinikleri J Med Sci 25:621-626
3. Wener MH, Hutchinson K, Morishima C, Gretch DR (2004) Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis Rheum 50(7):2305-2308. doi:10.1002/art.20355 (Pubitemid 38924410)
4. Lienesch D, Morris R, Metzger A, Debuys P, Sherman K (2005) Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. J Rheumatol 32(3):489-493
5. Bombardieri M, Alessandri C, Labbadia G, Iannuccelli C, Carlucci F, Riccieri V et al (2004) Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infectionassociated polyarticular involvement. Arthritis Res Ther 6(2):R137-R141. doi:10.1186/ar1041
6. Liu FC, Chao YC, Hou TY, Chen HC, Shyu RY, Hsieh TY et al (2008) Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia. Clin Rheumatol 27(4):463-467. doi: 10.1007/s10067-007-0729-4 (Pubitemid 351404301)
7. Sène D, Ghillani-Dalbin P, Limal N, Thibault V, van Boekel T, Piette JC et al (2006) Anti-cyclic citrullinated peptide antibodies in hepatitis C virus-associated rheumatological manifestations and Sjogren's syndrome. Ann Rheum Dis 65(3):394-397. doi: 10.1136/ard.2005.038042 (Pubitemid 43268232)
8. Lienesch D, Morris R, Metzger A, Debuys P, Sherman K (2005) Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. Rheumatology 32(3):489-493
9. Lee SI, Yoo WH, Yun HJ, Kim DS, Lee HS, Choi SI et al (2007) Absence of antibody to cyclic citrullinated peptide in sera of nonarthritic patients with chronic hepatitis B virus infection. Clin Rheumatol 26(7):1079-1082. doi:10.1007/s10067-006-0451-7 (Pubitemid 46863948)
10. Squadrito G, Previti M, Lenzi M, Le Rose EP, Caccamo G, Restuccia T et al (2003) High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. Dig Dis Sci 48(2):349-353. doi:10.1023/ A:1021991813586
11. Vannini A, Cheung K, Fusconi M, Stammen-Vogelzangs J, Drenth JP, Dall'Aglio AC et al (2007) Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis 66(4):511-516. doi: 10.1136/ard.2006.058933 (Pubitemid 46580473)
12. Sauerland U, Becker H, Seidel M, Schotte H, Willeke P, Schorat A et al (2005) Clinical utility of the anti-CCP assay: experiences with 700 patients. Ann N Y Acad Sci 1050:314-318. doi: 10.1196/annals.1313.033 (Pubitemid 41129449)
13. Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L et al (1999) Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 45(3):328-329
14. Harris ED (2005) Clinical features of rheumatoid arthritis. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB (eds) Kelly's textbook of rheumatology, vol II, 7th edn. Elsevier Saunders, Philadelphia, pp 1043-1100
15. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S et al (2007) Meta-analysis: diagnostic accuracy of anticyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146(11):797-808
16. Girelli F, Foschi FG, Bedeschi E, Calderoni V, Stefanini GF, Martinelli MG (2004) Is anti-cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? Eur Ann Allergy Clin Immunol 36(4):127-130
17. Riccio A, Postiglione L, La Dogana P, Spanò A, Marzocchella C, Tarantino G (2008) Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis. J Biol Regul Homeost Agents 22(1):57-61
18. Koga T, Migita K, Miyashita T, Maeda Y, Nakamura M, Abiru S et al (2008) Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with liver diseases. Clin Exp Rheumatol 26(1):121-124